Sex-Biased Associations of Circulating Ferroptosis Inhibitors with Reduced Lipid Peroxidation and Better Neurocognitive Performance in People with HIV

• Published in: Antioxidants 2024-08, Vol.13 (9), p.1042
• Main Authors: Kaur, Harpreet, Alluri, Ravi K, Wu, Kunling, Kalayjian, Robert C, Bush, William S, Palella, Frank J, Koletar, Susan L, Hileman, Corrilynn O, Erlandson, Kristine M, Ellis, Ronald J, Bedimo, Roger J, Taiwo, Babafemi O, Tassiopoulos, Katherine K, Kallianpur, Asha R
• Format: Article
• Language: English
• Subjects: Anemia; Biomarkers; Cognition; Comorbidity; Education; Efavirenz; Ethnicity; Ferritin; ferritin heavy chain; ferritin light chain; Ferroptosis; Hepatitis C; Highly active antiretroviral therapy; HIV; HIV (Viruses); HIV patients; Human immunodeficiency virus; Inflammation; Iron; Isoprostanes; Lipid peroxidation; Males; Neuropathogenesis; Neuroprotection; Observational studies; Oxidative stress; Proteins; Regression analysis; Risk factors; Sex differences; Standard scores; Substance abuse; Variables
• ISSN: 2076-3921; 2076-3921
• DOI: 10.3390/antiox13091042

Ferroptosis is implicated in viral neuropathogenesis and may underlie HIV-associated neurocognitive impairment (NCI). Emerging data also suggest differences in brain iron transport by sex. We hypothesized that circulating ferritins that inhibit ferroptosis associate with neurocognitive function and NCI in people with HIV (PWH) in a sex-biased manner. Serum ferritin heavy-chain-1 (FTH1), ferritin light-chain (FTL), and urinary F -isoprostanes (uF -isoPs, specific lipid peroxidation marker) were quantified in 324 PWH (including 61 women) with serial global (NPZ-4) and domain-specific neurocognitive testing. Biomarker associations with neurocognitive test scores and NCIs were evaluated by multivariable regression; correlations with uF -isoPs were also assessed. Higher FTL and FTH1 levels were associated with less NCI in all PWH (adjusted odds ratios 0.53, 95% confidence interval (95% CI) 0.36-0.79 and 0.66, 95% CI 0.45-0.97, respectively). In women, higher FTL and FTH1 were also associated with better NPZ-4 (FTL adjusted (β) = 0.15, 95% CI 0.02-0.29; FTL-by-sex β = 0.32, = 0.047) and domain-specific neurocognitive test scores. Effects on neurocognitive performance persisted for up to 5 years. Levels of both ferritins correlated inversely with uF -isoPs in women (FTL: = -0.47, 0.001). Circulating FTL and FTH1 exert sustained, sex-biased neuroprotective effects in PWH, possibly by protecting against iron-mediated lipid peroxidation (ferroptosis). Larger studies are needed to confirm the observed sex differences and further delineate the underlying mechanisms.